David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$986M |
| 2 |
Sea Limited
SE
|
+$480M |
| 3 |
Snowflake
SNOW
|
+$441M |
| 4 |
Citigroup
C
|
+$422M |
| 5 |
Oracle
ORCL
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$575M |
| 2 |
Apple
AAPL
|
+$515M |
| 3 |
Mastercard
MA
|
+$506M |
| 4 |
Walt Disney
DIS
|
+$447M |
| 5 |
Alibaba
BABA
|
+$434M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.89% |
| 2 | Technology | 13.97% |
| 3 | Consumer Discretionary | 9.19% |
| 4 | Financials | 7.48% |
| 5 | Healthcare | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCAF
2901
DELISTED
Mountain Crest Acquisition Corp. IV Common Stock
MCAF
| $2.76M | ﹤0.01% |
279,949
+12,048
| +4% | +$118K |
|
2902
Madrigal Pharmaceuticals
MDGL
$12.3B
| $2.75M | ﹤0.01% |
32,492
-5,732
| -15% | -$471K |
|
2903
MiMedx Group
MDXG
$656M
| $2.75M | ﹤0.01% |
455,820
+266,901
| +141% | +$1.85M |
|
|
DRE
2904
DELISTED
Duke Realty Corp.
DRE
| $2.75M | ﹤0.01% |
41,937
+2,680
| +7% | +$155K |
|
2905
PUT
Huazhu Hotels Group
HTHT
$14.7B
| $2.75M | ﹤0.01% |
73,700
+50,300
| +215% | +$2.2M |
|
|
FTPA
2906
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $2.75M | ﹤0.01% |
278,901
+43,232
| +18% | +$424K |
|
2907
PUT
FIVE9
FIVN
$2.54B
| $2.75M | ﹤0.01% |
+20,000
| New | +$2.96M |
|
2908
Bank of Hawaii
BOH
$3.05B
| $2.74M | ﹤0.01% |
32,733
+14,005
| +75% | +$1.18M |
|
2909
Banc of California
BANC
$2.95B
| $2.74M | ﹤0.01% |
139,638
+36,647
| +36% | +$742K |
|
2910
CALL
Everest Group
EG
$14.5B
| $2.74M | ﹤0.01% |
10,000
| – | – |
|
|
LJPC
2911
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.74M | ﹤0.01% |
588,802
-21,852
| -4% | -$91.1K |
|
|
BZUN
2912
PUT
Baozun
BZUN
$176M
| $2.73M | ﹤0.01% |
196,700
+54,700
| +39% | +$896K |
|
|
MRTX
2913
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.73M | ﹤0.01% |
18,600
-10,800
| -37% | -$1.68M |
|
2914
CALL
Edison International
EIX
$27B
| $2.72M | ﹤0.01% |
39,900
-5,900
| -13% | -$374K |
|
2915
Terreno Realty
TRNO
$7.26B
| $2.72M | ﹤0.01% |
31,919
+27,883
| +691% | +$2.1M |
|
2916
Pearson
PSO
$10.1B
| $2.72M | ﹤0.01% |
323,982
+301,806
| +1,361% | +$2.59M |
|
|
CVGW
2917
DELISTED
Calavo Growers
CVGW
| $2.72M | ﹤0.01% |
64,115
-31,997
| -33% | -$1.31M |
|
2918
CALL
ON Semiconductor
ON
$28.3B
| $2.72M | ﹤0.01% |
40,000
| – | – |
|
2919
CALL
Valero Energy
VLO
$101B
| $2.71M | ﹤0.01% |
36,100
-35,900
| -50% | -$2.67M |
|
|
SGI
2920
Somnigroup International
SGI
$13.5B
| $2.71M | ﹤0.01% |
57,605
-253,495
| -81% | -$11.5M |
|
|
OMEG
2921
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| $2.71M | ﹤0.01% |
277,063
+202,117
| +270% | +$1.97M |
|
2922
Entravision Communication
EVC
$745M
| $2.71M | ﹤0.01% |
399,109
-158,857
| -28% | -$1.2M |
|
2923
Forward Air
FWRD
$574M
| $2.71M | ﹤0.01% |
22,344
-18,512
| -45% | -$1.89M |
|
2924
Syndax Pharmaceuticals
SNDX
$1.74B
| $2.7M | ﹤0.01% |
123,303
-213,843
| -63% | -$3.95M |
|
2925
Century Aluminum
CENX
$4.61B
| $2.7M | ﹤0.01% |
162,799
+93,518
| +135% | +$1.37M |
|
Similar funds
David Shaw's Q4 2021 Portfolio in Review
As of Q4 2021, David Shaw held 5,958 positions worth $121B, up 8.8% from $111B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $7.58B in Q4 2021, closing 616 positions and reducing 1,595 holdings. Its most notable exit was Aon, an estimated $179M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares Core S&P 500 ETF worth $1.02B.
- David Shaw's largest Q4 2021 buy was iShares Core S&P 500 ETF: 2,140,000 shares worth $1.02B.
- David Shaw added most to Sea Limited in Q4 2021, an estimated $480M increase.
- David Shaw's biggest Q4 2021 reduction was Microsoft, cutting an estimated $575M.
- David Shaw fully exited Aon in Q4 2021, selling an estimated $179M.
- David Shaw's ten largest holdings make up 9.2% of its $121B portfolio in Q4 2021.
- David Shaw opened 1,032 new positions and closed 616 in Q4 2021.
- David Shaw's portfolio value rose 8.8% quarter-over-quarter to $121B.
Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.